{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T19:10:08Z","timestamp":1734203408348,"version":"3.30.2"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,14]]},"DOI":"10.7759\/cureus.75710","type":"journal-article","created":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T18:31:33Z","timestamp":1734201093000},"source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Factors of Hodgkin's Disease Recurrence: An Experience From a Tertiary Academic Center in Iran"],"prefix":"10.7759","author":[{"given":"Sharareh","family":"Seifi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Esfahanimonfared","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Moeini Nia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.5958","article-title":"High familial risk in nodular lymphocyte-predominant Hodgkin lymphoma","volume":"31","author":"Saarinen S","year":"2013","unstructured":"Saarinen S, Pukkala E, Vahteristo P, M\u00e4kinen MJ, Franssila K, Aaltonen LA. High familial risk in nodular lymphocyte-predominant Hodgkin lymphoma. J Clin Oncol. 2013, 31:938-43. 10.1200\/JCO.2012.43.5958","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1532\/IJH97.05184","article-title":"Epidemiology and pathologic features of Hodgkin lymphoma","volume":"83","author":"Nakatsuka S","year":"2006","unstructured":"Nakatsuka S, Aozasa K. Epidemiology and pathologic features of Hodgkin lymphoma. Int J Hematol. 2006, 83:391-7. 10.1532\/IJH97.05184","journal-title":"Int J Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2019.1598678","article-title":"Clinical characteristics and prognostic factors of primary extranodal classical Hodgkin lymphoma: a retrospective study","volume":"24","author":"Yang M","year":"2019","unstructured":"Yang M, Ping L, Liu W, et al.. Clinical characteristics and prognostic factors of primary extranodal classical Hodgkin lymphoma: a retrospective study. Hematology. 2019, 24:413-9. 10.1080\/16078454.2019.1598678","journal-title":"Hematology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22799","article-title":"Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets","volume":"8","author":"Mata E","year":"2017","unstructured":"Mata E, D\u00edaz-L\u00f3pez A, Mart\u00edn-Moreno AM, et al.. Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets. Oncotarget. 2017, 8:111386-95. 10.18632\/oncotarget.22799","journal-title":"Oncotarget"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15778","article-title":"Biology and therapy of primary mediastinal B-cell lymphoma: current status and future directions","volume":"185","author":"Lees C","year":"2019","unstructured":"Lees C, Keane C, Gandhi MK, Gunawardana J. Biology and therapy of primary mediastinal B-cell lymphoma: current status and future directions. Br J Haematol. 2019, 185:25-41. 10.1111\/bjh.15778","journal-title":"Br J Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow SH","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, et al.. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016, 127:2375-90. 10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting","volume":"7","author":"Lister TA","year":"1989","unstructured":"Lister TA, Crowther D, Sutcliffe SB, et al.. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol. 1989, 7:1630-6. 10.1200\/JCO.1989.7.11.1630","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer EA","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al.. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009, 45:228-47. 10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM199811193392104","article-title":"A prognostic score for advanced Hodgkin's disease. International prognostic factors project on advanced Hodgkin's disease","volume":"339","author":"Hasenclever D","year":"1998","unstructured":"Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International prognostic factors project on advanced Hodgkin's disease. N Engl J Med. 1998, 339:1506-14.","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2014.053","article-title":"Prognostic factors in hodgkin lymphoma","volume":"6","author":"Cuccaro A","year":"2014","unstructured":"Cuccaro A, Bartolomei F, Cupelli E, Galli E, Giachelia M, Hohaus S. Prognostic factors in hodgkin lymphoma. Mediterr J Hematol Infect Dis. 2014, 6:e2014053. 10.4084\/MJHID.2014.053","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21438","article-title":"Hodgkin lymphoma: a review and update on recent progress","volume":"68","author":"Shanbhag S","year":"2018","unstructured":"Shanbhag S, Ambinder RF. Hodgkin lymphoma: a review and update on recent progress. CA Cancer J Clin. 2018, 68:116-32. 10.3322\/caac.21438","journal-title":"CA Cancer J Clin"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1522435","article-title":"Inferior outcomes and treatment disparities in elderly patients with classical Hodgkin lymphoma: a national cancer data base analysis","volume":"60","author":"Major A","year":"2019","unstructured":"Major A, Jackson MW, Smith DE, Kamdar M, Rabinovitch R. Inferior outcomes and treatment disparities in elderly patients with classical Hodgkin lymphoma: a national cancer data base analysis. Leuk Lymphoma. 2019, 60:1234-43. 10.1080\/10428194.2018.1522435","journal-title":"Leuk Lymphoma"},{"key":"ref13","article-title":"The changing trends of adult Hodgkin's disease in Saudi Arabia","volume":"24","author":"Al-Diab AI","year":"2003","unstructured":"Al-Diab AI, Siddiqui N, Sogiawalla FF, Fawzy EM. The changing trends of adult Hodgkin's disease in Saudi Arabia. Saudi Med J. 2003, 24:617-22.","journal-title":"Saudi Med J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5851.177038","article-title":"Hodgkin lymphoma: a clinicopathological and immunophenotypic study","volume":"37","author":"Konkay K","year":"2016","unstructured":"Konkay K, Paul TR, Uppin SG, Rao DR. Hodgkin lymphoma: a clinicopathological and immunophenotypic study. Indian J Med Paediatr Oncol. 2016, 37:59-65. 10.4103\/0971-5851.177038","journal-title":"Indian J Med Paediatr Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01281-9","article-title":"Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis","volume":"15","author":"Huang J","year":"2022","unstructured":"Huang J, Pang WS, Lok V, et al.. Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis. J Hematol Oncol. 2022, 15:57. 10.1186\/s13045-022-01281-9","journal-title":"J Hematol Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-69975-3","article-title":"Adult Hodgkin lymphoma incidence trends in the United States from 2000 to 2020","volume":"14","author":"Aslani A","year":"2024","unstructured":"Aslani A, Morsali S, Mousavi SE, Choupani S, Yekta Z, Nejadghaderi SA. Adult Hodgkin lymphoma incidence trends in the United States from 2000 to 2020. Sci Rep. 2024, 14:20500. 10.1038\/s41598-024-69975-3","journal-title":"Sci Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2016.17.1.101","article-title":"Treating adults with Hodgkin lymphoma in the developing world: a hospital-based cohort study from Armenia","volume":"17","author":"Avagyan A","year":"2016","unstructured":"Avagyan A, Danielyan S, Voskanyan A, et al.. Treating adults with Hodgkin lymphoma in the developing world: a hospital-based cohort study from Armenia. Asian Pac J Cancer Prev. 2016, 17:101-4. 10.7314\/apjcp.2016.17.1.101","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195629","article-title":"Overview and outcome of Hodgkin's lymphoma: experience of a single developing country's oncology centre","volume":"13","author":"Shamoon RP","year":"2018","unstructured":"Shamoon RP, Ali MD, Shabila NP. Overview and outcome of Hodgkin's lymphoma: experience of a single developing country's oncology centre. PLoS One. 2018, 13:e0195629. 10.1371\/journal.pone.0195629","journal-title":"PLoS One"},{"key":"ref19","article-title":"Assessing prognostic factors in Hodgkin's lymphoma: multistate illness-death model","volume":"12","author":"Javanmardi F","year":"2018","unstructured":"Javanmardi F, Saki-Malehi A, Ahmadzadeh A, Rahim F. Assessing prognostic factors in Hodgkin's lymphoma: multistate illness-death model. Int J Hematol Oncol Stem Cell Res. 2018, 12:57-64.","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.hsr.2023.100117","article-title":"Classical Hodgkin lymphoma histologic subtypes distribution among geographical regions and correlation with Human Development Index","volume":"9","author":"Moscona-Nissan A","year":"2023","unstructured":"Moscona-Nissan A, Mancilla-Osuna MF, Bard\u00e1n-Duarte A, Rend\u00f3n-Mac\u00edas ME. Classical Hodgkin lymphoma histologic subtypes distribution among geographical regions and correlation with Human Development Index. Health Sci Rev. 2023, 9:100117. 10.1016\/j.hsr.2023.100117","journal-title":"Health Sci Rev"},{"key":"ref21","article-title":"Hodgkin's disease: assessment of treatment and survival rates in Iran","volume":"5","author":"Iraj AK","year":"2004","unstructured":"Iraj AK. Hodgkin's disease: assessment of treatment and survival rates in Iran. Asian Pac J Cancer Prev. 2004, 5:379-82.","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.799948","article-title":"Real-world outcomes of Hodgkin lymphoma: a multi-centric registry from India","volume":"11","author":"Bhurani D","year":"2021","unstructured":"Bhurani D, Nair R, Rajappa S, et al.. Real-world outcomes of Hodgkin lymphoma: a multi-centric registry from India. Front Oncol. 2021, 11:799948. 10.3389\/fonc.2021.799948","journal-title":"Front Oncol"},{"key":"ref23","article-title":"Mediastinal involvement in Hodgkin's disease: prognostic factors and distribution of intrathoracic adenopathies","volume":"2","author":"Cionini L","year":"1982","unstructured":"Cionini L, Villari N, Ponticelli P, Biti GP, Mungai V. Mediastinal involvement in Hodgkin's disease: prognostic factors and distribution of intrathoracic adenopathies. Eur J Radiol. 1982, 2:301-6.","journal-title":"Eur J Radiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27470","article-title":"Hodgkin lymphoma: 2025 update on diagnosis, risk-stratification, and management","volume":"99","author":"Ansell SM","year":"2024","unstructured":"Ansell SM. Hodgkin lymphoma: 2025 update on diagnosis, risk-stratification, and management. Am J Hematol. 2024, 99:2367-78. 10.1002\/ajh.27470","journal-title":"Am J Hematol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2589","article-title":"Treating Hodgkin lymphoma in the new millennium: relapsed and refractory disease","volume":"37","author":"LaCasce AS","year":"2019","unstructured":"LaCasce AS. Treating Hodgkin lymphoma in the new millennium: relapsed and refractory disease. Hematol Oncol. 2019, 37:87-91. 10.1002\/hon.2589","journal-title":"Hematol Oncol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu181","article-title":"Hodgkin's lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Eichenauer DA","year":"2014","unstructured":"Eichenauer DA, Engert A, Andr\u00e9 M, Federico M, Illidge T, Hutchings M, Ladetto M. Hodgkin's lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014, 25:iii70-5. 10.1093\/annonc\/mdu181","journal-title":"Ann Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2450","article-title":"Treatment outcomes for Hodgkin lymphoma: first report from the Brazilian Prospective Registry","volume":"36","author":"Biasoli I","year":"2018","unstructured":"Biasoli I, Castro N, Delamain M, et al.. Treatment outcomes for Hodgkin lymphoma: first report from the Brazilian Prospective Registry. Hematol Oncol. 2018, 36:189-95. 10.1002\/hon.2450","journal-title":"Hematol Oncol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1159\/000460819","article-title":"Hodgkin lymphoma outcome: a retrospective study from 3 tertiary centers in Saudi Arabia","volume":"40","author":"Shafi RG","year":"2017","unstructured":"Shafi RG, Al-Mansour MM, Kanfar SS, Al Hashmi H, Alsaeed A, Al-Foheidi M, Ibrahim EM. Hodgkin lymphoma outcome: a retrospective study from 3 tertiary centers in Saudi Arabia. Oncol Res Treat. 2017, 40:288-92. 10.1159\/000460819","journal-title":"Oncol Res Treat"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.07.019","article-title":"Outcomes of advanced Hodgkin lymphoma after umbilical cord blood transplantation: a Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party Study","volume":"24","author":"Paviglianiti A","year":"2018","unstructured":"Paviglianiti A, Tozatto Maio K, Rocha V, et al.. Outcomes of advanced Hodgkin lymphoma after umbilical cord blood transplantation: a Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party Study. Biol Blood Marrow Transplant. 2018, 24:2265-70. 10.1016\/j.bbmt.2018.07.019","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/507257","article-title":"HIV-associated Hodgkin's lymphoma: prognosis and therapy in the era of cART","volume":"2012","author":"Jacobson CA","year":"2012","unstructured":"Jacobson CA, Abramson JS. HIV-associated Hodgkin's lymphoma: prognosis and therapy in the era of cART. Adv Hematol. 2012, 2012:507257. 10.1155\/2012\/507257","journal-title":"Adv Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/317874-prognostic-factors-of-hodgkins-disease-recurrence-an-experience-from-a-tertiary-academic-center-in-iran","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T18:31:35Z","timestamp":1734201095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/317874-prognostic-factors-of-hodgkins-disease-recurrence-an-experience-from-a-tertiary-academic-center-in-iran"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,14]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.75710","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,14]]}}}